Skip to main content
Signal8

Carmona Jose

SEC insider (Form 3/4/5 filer). CIK 0001693612. Chief Financial Officer at ADC Therapeutics SA (ADCT). 6 reported Form 4/5 transactions since Sep 2024; latest on Jun 30, 2026. Located in NEW PROVIDENCE, NJ.

Companies Carmona Jose has filed insider reports for

  • ADC Therapeutics SA (ADCT): Officer, Chief Financial Officer
Carmona Jose profile photo

Carmona Jose

CIK: 0001693612

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)3 (50.0%)

Compensation grants

Other (G, F, J, C, D, …)3 (50.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

ADC Therapeutics SA logo
ADCT

ADC Therapeutics SA

Officer

Discretionary Trading P&L

Holdings

Transaction History (6 total)

  • ADC Therapeutics SA logo
    ADCT

    ADC Therapeutics SA

    Jun 30, 2026
    Award
    Direct
    203.7K shares-
  • ADC Therapeutics SA logo
    ADCT

    ADC Therapeutics SA

    Feb 13, 2026
    Award
    Direct
    271.6K shares at avg. $3.99$1.1M
  • ADC Therapeutics SA logo
    ADCT

    ADC Therapeutics SA

    Feb 13, 2026
    Tax Payment
    Direct
    25.9K shares at avg. $3.99$103K
  • ADC Therapeutics SA logo
    ADCT

    ADC Therapeutics SA

    Dec 6, 2025
    Tax Payment
    Direct
    53.2K shares at avg. $3.29$175K
  • ADC Therapeutics SA logo
    ADCT

    ADC Therapeutics SA

    Feb 13, 2025
    Award
    Direct
    240K shares at avg. $1.61$386K
  • ADC Therapeutics SA logo
    ADCT

    ADC Therapeutics SA

    Dec 6, 2024
    Tax Payment
    Direct
    48.1K shares at avg. $3.13$151K

1-6 of 6